MEDX ETF holdings (NASDAQ) | MetaTrader

Apri il grafico completo

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

LLY Eli Lilly & Co 3.52 M 2 936.00 18.46%

US BANK MMDA - USBGFS 7 1.75 M 1.75 M 9.19%

ABBV AbbVie Inc 1.69 M 6 712.00 8.85%

NVS Novartis AG 1.31 M 8 388.00 6.89%

JNJ Johnson & Johnson 1.07 M 4 200.00 5.59%

ALKS Alkermes PLC 1.05 M 20.13 K 5.53%

A

AZN AstraZeneca PLC 950.94 K 5 015.00 4.98%

IONS Ionis Pharmaceuticals Inc 864.58 K 10.90 K 4.53%

BMY Bristol-Myers Squibb Co 843.79 K 14.64 K 4.42%

MRK Merck & Co Inc 754.55 K 5 872.00 3.96%

AMGN Amgen Inc 746.69 K 2 062.00 3.91%

ALNY Alnylam Pharmaceuticals Inc 652.63 K 2 168.00 3.42%

BIIB Biogen Inc 588.98 K 2 726.00 3.09%

PFE Pfizer Inc 545.36 K 22.65 K 2.86%

GSK GSK PLC 516.13 K 9 846.00 2.71%

CRSP CRISPR Therapeutics AG 503.30 K 9 228.00 2.64%

REGN Regeneron Pharmaceuticals Inc 392.83 K 630.00 2.06%

BEAM Beam Therapeutics Inc 287.88 K 8 388.00 1.51%

GALT Galectin Therapeutics Inc 217.93 K 46.97 K 1.14%

NTLA Intellia Therapeutics Inc 212.92 K 12.58 K 1.12%

1
2

Notizie

Medmix: ricavi 2025 in calo, dividendo tagliato dell’80%; azioni giù del 17%

Medmix FY 2025: i margini balzano di 90 punti base mentre i ricavi calano del 7,4%

Stifel avvia copertura su Medmix con rating Buy e target di CHF14,50